Seckinger, A. (20 July 2018). CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma - association with molecular entities, risk, survival, and mechanisms of upfront resistance. Frontiers in immunology, 9, . doi:10.3389/fimmu.2018.01676

"CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma - association with molecular entities, risk, survival, and mechanisms of upfront resistance / Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Michael Hundemer, Anna Jauch, Ute Hegenbart, Marc-Steffen Raab, Anthony D. Ho, Stefan Schönland and Dirk Hose" Frontiers in Immunology .

Seckinger, Anja. "CD38 As Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma - Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance." Frontiers in Immunology 9 (20 July 2018).